Satellos Bioscience Inc. (Nasdaq: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, ...
The trial of nine suspected members of a self-admitted antifa cell is restarting, following an abrupt mistrial declared last week, as they face federal terrorism-related charges stemming from their ...
In mCRPC patients with androgen receptor (AR) mutations, treatment with MRT-2359 in combination with enzalutamide led to a 100% PSA response rate ...
Deep in our cells, a wide range of processes are occurring constantly. These cellular processes rely on enzymes to act as catalysts and set off a series of molecular interactions. There are still many ...
Sometimes, transporting electrons from one cell to another is a team effort. In electroactive bacteria, that team is a group ...
In mCRPC patients with androgen receptor (AR) mutations, treatment with MRT-2359 in combination with enzalutamide led to a 100% PSA response rate (5 of 5 patients) and a 100% disease control rate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results